REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) › Operating IncomeREVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: -$376.9K2020: -$2.43M2021: -$10.10M2022: -$28.23M2023: -$39.50M2024: -$30.80M2025: -$20.20M-$20.20M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$20.20M+34.4%2024-$30.80M+22.0%2023-$39.50M-39.9%2022-$28.23M-179.4%2021-$10.10M-315.0%2020-$2.43M-546.0%2019-$376.9K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share